1
|
Maziere M, Rompante P, Andrade JC, De Oliveira BSF, Alves MC, Rodrigues CF. Repurposing Mouthwashes: Antifungal and Antibiofilm Abilities of Commercially Available Mouthwashes Against Candida spp. Antibiotics (Basel) 2025; 14:483. [PMID: 40426549 PMCID: PMC12108391 DOI: 10.3390/antibiotics14050483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2025] [Revised: 05/05/2025] [Accepted: 05/06/2025] [Indexed: 05/29/2025] Open
Abstract
Background/Objectives: The main objective was to evaluate and compare the antifungal efficacy against Candida spp. in commercially available mouthwashes distributed in the European market. Indeed, the solution to emerging infectious diseases may no longer lie in costly new drug development but rather in unlocking the untapped potential of existing substances. Materials and Methods: Eighteen mouthwashes, chosen based on their composition, were tested in vitro against ten Candida strains, including clinical isolates of oral origin and reference strains, in both planktonic and biofilm forms. The antifungal susceptibility testing was conducted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) disc diffusion method and the evaluation of the kinetic growth in planktonic Candida. Biofilm reduction was determined by the evaluation of the minimal biofilm eradication concentration (MBEC). Scanning electron microscopy (SEM) analysis was performed to evaluate potential morphological alterations of Candida biofilms. Results: Most mouthwashes effectively reduced biomass production and colony-forming unit (CFU) count. Parodontax Extra showed the highest efficacy. In the disc diffusion assay, Gum Paroex 0.12% exhibited the largest average inhibition zone diameter. Some unusual trends in the data may be explained by a higher reaction of fungal cells and the release of excess biomass during co-incubation in higher concentration of mouthwashes. SEM images revealed significant morphological alterations. Conclusion: Mouthwashes containing chlorhexidine digluconate, either alone or in combination with cetylpyridinium chloride and other active compounds, emerged as a common factor among the most efficacious formulations. In vivo studies will be essential to validate these findings, but mouthwashes may serve as a valuable adjuvant in the treatment of oral candidiasis.
Collapse
Affiliation(s)
- Marie Maziere
- UNIPRO—Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal; (M.M.); (P.R.)
| | - Paulo Rompante
- UNIPRO—Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal; (M.M.); (P.R.)
| | - José Carlos Andrade
- Associate Laboratory i4HB—Institute for Health and Bioeconomy, University Institute of Health Sciences (IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal;
- UCIBIO—Applied Molecular Biosciences Unit, Forensics and Biomedical Sciences Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal
| | - Beatriz S. F. De Oliveira
- Microbiology Laboratory, University Institute of Health Sciences (IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal; (B.S.F.D.O.); (M.C.A.)
| | - Mariana C. Alves
- Microbiology Laboratory, University Institute of Health Sciences (IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal; (B.S.F.D.O.); (M.C.A.)
| | - Celia Fortuna Rodrigues
- Associate Laboratory i4HB—Institute for Health and Bioeconomy, University Institute of Health Sciences (IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal;
- UCIBIO—Applied Molecular Biosciences Unit, Forensics and Biomedical Sciences Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), Avenida Central de Gandra 1317, 4585-116 Gandra PRD, Portugal
- ALiCE/LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal
| |
Collapse
|